CAMBRIDGE, Mass., Jan. 24 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation
at the Wachovia 2008 Healthcare Conference will be webcast live and may be
accessed by visiting the Investors section of the Company's website,
http://www.millennium.com.
The presentation will include an overview of the Company, VELCADE(R)
(bortezomib) for Injection and other product candidates. The presentation
will be delivered at 2:00 p.m. ET on Thursday, January 31, 2008 from the
Langham Hotel in Boston, MA. The presentation will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has
a robust clinical development pipeline of product candidates. The Company's
research, development and commercialization activities are focused in two
therapeutic areas: oncology and inflammation. By applying its knowledge of
the human genome, understanding of disease mechanisms and industrialized
drug discovery platform, Millennium is developing an exciting pipeline of
innovative product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media
section of the Company's website at: http://www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com/
http://www.prnewswire.com/comp/114562.html/
CONTACT:
Kyle Kuvalanka, of Millennium
Pharmaceuticals, Inc., +1-617-761- 4734
|
